![]() |
市场调查报告书
商品编码
1453015
造口设备市场:成长、未来前景、竞争分析,2023-2031 年Insufflation Devices Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031 |
结肠造口设备市场的特点是腹腔镜手术的进步、肥胖治疗需求的增加以及心臟手术应用的扩大。 儘管分销管道面临挑战,但市场仍显示出韧性和成长潜力。 预计 2024 年至 2032 年,结肠造口设备市场将以 6.7% 的复合年增长率成长。 细分分析显示,受技术创新和患者人口统计变化的影响,手术偏好和分销管道趋势正在改变。 区域商机多样,竞争趋势凸显持续研发的必要性。 随着造口设备市场进入 2023 年的预测期,利害关係人必须克服挑战并利用新机遇,以确保全球这个重要医疗保健产业的持续成长。但这种情况不会发生。
腹腔镜手术技术的进展
腹腔镜手术技术的进步是推动结肠造口设备市场的关键因素。 外科医生和医疗机构,包括梅奥诊所等着名医疗中心,正在拥抱腹腔镜手术并为其发展做出贡献。 支持这项推动的证据包括同行评审的研究和医学期刊,记录了与腹腔镜手术相关的患者治疗效果的改善和恢復时间的缩短。
减重手术的需求不断增加
在全球肥胖率上升的背景下,减重手术的需求不断增加,这是结肠造口设备的主要驱动力。 世界卫生组织 (WHO) 等领先的医疗保健组织强调减重手术在管理肥胖相关健康问题的重要性。 流行病学数据和减重手术的增加证明了这种推动力,凸显了结肠造口设备在这些手术中的重要作用。
扩大在心臟手术的应用
结肠造口设备越来越多地用于心臟手术,促进了市场成长。 克利夫兰诊所等着名心臟中心将气腹技术纳入其微创心臟手术中。 这项推动得到了临床证据和同行评审文献的支持,证明结肠造口设备在提高心臟手术的手术精度和患者预后方面具有积极影响。
零售药局和其他通路面临的挑战
儘管市场整体成长,但结肠造口设备的分销仍面临挑战。 监管限制、特殊储存要求以及严格品质控制的需求等问题都是限制因素。 医疗保健提供者在采购和维护这些专用医疗设备的供应链时所面临的挑战证明了这个限制。
依应用市场分析:腹腔镜手术占据市场主导地位
在细分分析中,应用是影响市场动态的重要因素。 2023年,腹腔镜手术占据市场主导地位,收入最高。 然而,在 2024 年至 2032 年的预测期内,减重手术的收入和复合年增长率 (CAGR) 预计将超过腹腔镜手术。 肥胖盛行率的增加和对肥胖治疗介入的接受程度的提高就证明了这种转变。
依通路划分的市场分析:零售药局主导市场
分销管道是市场区隔的一个重要方面,反映了访问医疗保健提供者方式的变化。 截至2023年,零售药局是主要分销管道,收入最高。 然而,在 2024 年至 2032 年的预测期内,电子商务预计将显示出最高的收入和预计复合年增长率,这表明分销格局发生了变化。
北美仍处于世界领先地位
依地区划分,结肠造口器材市场呈现不同的趋势。 在医疗基础设施不断增加和微创手术技术采用的推动下,预测期内复合年增长率最高的地区预计将是亚太地区。 同时,北美预计将维持其销售比例最高地区的地位,反映出市场成熟,拥有成熟的医疗器材製造商。
预测期内市场竞争将会加剧
主要公司包括美敦力(Medtronic)、爱惜康(Ethicon)、Karl Storz、奥林巴斯公司(Olympus Corporation)、富士胶卷(Fujifilm)、史赛克(Stryker)、BD、B. Braun Melsungen、施乐辉(Smith & Nephew)、Steris、CONMED 与Richard Wolf。 这些公司透过专注于持续创新、策略合作伙伴关係和满足医疗保健提供者的独特需求,在塑造竞争趋势方面发挥关键作用。 整体前景凸显了该行业对外科技术进步的承诺,并强调了适应不断变化的市场动态的重要性。
本报告回答的主要问题
The insufflation devices market is characterized by advancements in laparoscopic surgery, the increasing demand for bariatric procedures, and expanding applications in cardiac surgery. Despite challenges in distribution channels, the market demonstrates resilience and potential for growth. The insufflation devices market is expected to grow at a CAGR of 6.7% from 2024 to 2032. The segmentation analysis reveals shifting trends in surgical preferences and distribution channels, influenced by technological innovations and changing patient demographics. Geographically, diverse opportunities present themselves, while competitive trends highlight the need for continuous research and development. As the insufflation devices market progresses from 2023 into the forecast period, stakeholders must navigate challenges and capitalize on emerging opportunities, ensuring the sustained growth of this critical healthcare segment globally.
Advancements in Laparoscopic Surgery Techniques
Advancements in laparoscopic surgery techniques are a major driver propelling the insufflation devices market. Surgeons and healthcare institutions, including renowned medical centers like the Mayo Clinic, have embraced and contributed to the evolution of laparoscopic procedures. Evidence supporting this driver includes peer-reviewed studies and medical journals, showcasing the improved patient outcomes and reduced recovery times associated with laparoscopic surgery.
Increasing Demand in Bariatric Surgery
The increasing demand for bariatric surgery, driven by rising obesity rates globally, is a key driver for insufflation devices. Leading healthcare organizations like the World Health Organization (WHO) emphasize the importance of bariatric surgery in managing obesity-related health issues. This driver is substantiated by epidemiological data and the growing adoption of bariatric procedures, highlighting the indispensable role of insufflation devices in these surgeries.
Expanding Applications in Cardiac Surgery
insufflation devices are finding expanding applications in cardiac surgery, contributing to the market's growth. Notable cardiac centers, such as the Cleveland Clinic, have integrated insufflation technologies in minimally invasive cardiac procedures. This driver is supported by clinical evidence and peer-reviewed articles, illustrating the positive impact of insufflation devices in enhancing surgical precision and patient outcomes in cardiac surgeries.
Challenges in Retail Pharmacies and Other Distribution Channels
Despite the overall market growth, challenges persist in the distribution of insufflation devices. Issues such as regulatory constraints, specialized storage requirements, and the need for stringent quality control pose constraints. This restraint is supported by documented challenges faced by healthcare providers in procuring and maintaining a supply chain for these specialized medical devices.
Market Analysis by Application: Laparoscopic Surgery Dominates the Market
In the segmentation analysis, the application is a critical factor influencing market dynamics. In 2023, laparoscopic surgery dominated the market, generating the highest revenue. However, during the forecast period from 2024 to 2032, bariatric surgery is anticipated to surpass laparoscopic surgery in both revenue and the highest Compound Annual Growth Rate (CAGR). This shift is substantiated by the increasing prevalence of obesity and the growing acceptance of bariatric interventions.
Market Analysis by Distribution Channel: Retail Pharmacies Dominate the Market
The distribution channel is a key aspect of market segmentation, reflecting changes in the way insufflation devices reach healthcare providers. In 2023, retail pharmacies were a primary channel for distribution, contributing the highest revenue. Nevertheless, during the forecast period from 2024 to 2032, e-commerce is expected to exhibit both the highest revenue and the highest CAGR, signaling a transformative shift in the distribution landscape.
North America Remains the Global Leader
Geographically, the insufflation devices market exhibits diverse trends. The region with the highest CAGR during the forecast period is anticipated to be Asia-Pacific, driven by increasing healthcare infrastructure and the adoption of minimally invasive surgical techniques. Meanwhile, North America is expected to maintain its position as the region with the highest revenue percentage, reflecting a mature market with established medical device manufacturers.
Market Competition to Intensify during the Forecast Period
Top players in the insufflation devices market include Medtronic, Ethicon, Karl Storz, Olympus Corporation, Fujifilm, Stryker, BD, B. Braun Melsungen, Smith & Nephew, Steris, CONMED, and Richard Wolf. These companies play a crucial role in shaping competitive trends through continuous innovation, strategic partnerships, and a focus on addressing the unique needs of healthcare providers. The overall outlook emphasizes the industry's commitment to advancing surgical techniques and underscores the importance of adapting to evolving market dynamics.
Historical & Forecast Period
This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Insufflation Devices market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users and consumption volume, price and value.
Geographical revenues generate by countries considered in the report
Micro and macro environment factors that are currently influencing the Insufflation Devices market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Market Segmentation
Application
End-Use
Region Segment (2021-2031; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Key questions answered in this report
What are the key micro and macro environmental factors that are impacting the growth of Insufflation Devices market?
What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2031.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Insufflation Devices market?
Which is the largest regional market for Insufflation Devices market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Insufflation Devices market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Insufflation Devices market worldwide?
FIG. 9Market Positioning of Key Insufflation Devices Market Players, 2023
FIG. 10Global Insufflation Devices Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032